G
G

GSK


Balita

British Business - Sept 23

Sept 23 (Reuters) - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy. The Times The asset management business of HSBC Holdings Plc HSBA.L has set out plans to cut investments in thermal coal, months after one of its former top executives caused a furore with his comments about climate change.
G
H
R

UK Stocks-Factors to watch on Sept 20

Sept 20 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening higher on Tuesday, with futures FFIc1 up 0.57%. * HALEON: Haleon HLN.L said it had notified GSK GSK.L and Pfizer PFE.N that it had rejected their requests for indemnification in relation to U.S.-based litigation over the heartburn drug, Zantac. * FULLER: Fuller, Smith & Turner FSTA.L warned that the global energy crisis would significantly raise its expected full-year costs for gas and electricity.
G
K
P
T
U

UK Stocks-Factors to watch on Aug 17

Aug 17 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening up 0.36%, with futures .FFIc1 up 0.15% on Wednesday. * BOOHOO: British online fashion retailer Boohoo BOOH.L said on Wednesday it had acquired a 7.1% stake in Revolution Beauty Group REVB.L , making it the fourth-largest shareholder of the beauty products maker. * PERSIMMON: Persimmon PSN.L forecast robust demand for new homes and reiterated its annual home completions outlook, dispelling fears of a slowdown in the sector, althoug
C
G
P
U

Financial Times - Aug 17

Aug 17 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines - Liz Truss and Rishi Sunak rule out second Scottish independence vote Link - UK launches legal proceedings against EU over access to Horizon programme Link - AstraZeneca sues former executive over move to rival GSK Link - Philips chief exits in wake of fallout from medical device recall Link Overview - Foreign secretary Liz Truss, f
A
G
P

UK first to approve Omicron COVID shot with Moderna nod

* UK's JCVI backs using bivalent shot in autumn booster campaign * Moderna sees Australia, Canada, EU approvals soon By Natalie Grover LONDON, Aug 15 (Reuters) - Britain, the first country to approve a coronavirus vaccine in late 2020, has now also given the first green light to a variant-adapted shot that targets both the original and Omicron version of the virus.
A
G
P
S

Haleon not a party to U.S. litigation focused on Zantac - spokesperson

By Natalie Grover LONDON, Aug 11 (Reuters) - Haleon - GSK's recently spun off consumer health unit - is not a party to U.S. litigation focused on the heartburn medicine Zantac, a spokesperson told Reuters on Thursday. "We have never marketed Zantac in any form in the U.S., as Haleon or as GSK consumer healthcare," the spokesperson said, responding to Reuters querying a near-20% decline in Haleon's share price this week.
G
P
S

Haleon not a party to U.S. litigation focused on Zantac - spokesperson

LONDON, Aug 11 (Reuters) - Haleon - GSK's recently spun off consumer health unit - is not a party to the U.S. litigation focused on the heartburn medicine Zantac, a spokesperson told Reuters on Thursday. "We have never marketed Zantac in any form in the U.S., as Haleon or as GSK consumer healthcare," the spokesperson said in response to queries about sharp declines in Haleon shares.
G
S

FTSE 100 ends down as GSK slumps, eyes on GDP data

(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window) * Rio Tinto down on ex-dividend trading * GSK, Haleon slide on U.S. litigation concerns * Network International jumps on share buyback, earnings * FTSE 100 down 0.6%, FTSE 250 off 0.3% (Updates with market close) By Sruthi Shankar Aug 11 (Reuters) - Britain's main stock indexes closed lower on Thursday, with the blue-chip FTSE 100 hit by a slump in healthcare stocks and the midcap index slippin
A
A
G
N
R
U

FTSE 100 stalls as Rio Tinto, healthcare stocks weigh

(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window) * FTSE 100 flat, FTSE 250 adds 0.4% Aug 11 (Reuters) - Britain's top share index was flat on Thursday, weighed down by Rio Tinto and healthcare stocks, while the midcap index hit a fresh two-month high as global equities extended gains on relief from softer-than-expected U.S.
G
U

UK Stocks-Factors to watch on July 29

July 29(Reuters) - Britain's FTSE 100 index .FTSE is seen opening higher on Friday, with futures FFIc1 up 0.35%. * ASTRAZENECA: AstraZeneca AZN.L topped analyst expectations for second-quarter profit and revenue, helped by higher demand for its cancer medicines. * IAG: IAG IAG.L returned to quarterly profitability for the first time since the outbreak of the COVID-19 pandemic, following a "significant" increase in capacity.
A
C
E
G
G
I
I
J
R
S
U

UK Stocks-Factors to watch on July 29

July 29(Reuters) - Britain's FTSE 100 index .FTSE is seen opening higher on Friday, with futures FFIc1 up 0.2%. * STANCHART: Standard Chartered STAN.L on Friday reported that first-half pre-tax profit rose 19%, above market expectations, as the emerging markets-focused lender benefited from rising interest rates. * BUSINESS SENTIMENT: British business confidence fell this month to its lowest since March 2021 as companies worried about inflation, while pay pressures also increased, according to a
A
C
E
G
G
I
I
J
R
S
U

Cost of living crisis? Consumers keep spending for now

By Richa Naidu and Sachin Ravikumar LONDON, July 27 (Reuters) - Consumer-focused firms are seeing no shortage of demand despite the soaring cost-of-living, prompting several to upgrade sales forecasts for the current year, though questions remain about how long that will last. While some consumers are shielding themselves from price hikes by trading down to own label products, enough are spending more for McDonalds MCD.N to risk lifting the price of a cheeseburger in Britain for the first time i
C
D
G
L
P
K

UK Stocks-Factors to watch on July 27

July 27 (Reuters) - Britain's FTSE 100 index .FTSE is seen opening higher on Wednesday, with futures FFIc1 up 0.34%. * MARSTON'S: British pub group Marston's MARS.L said its sales for 42 weeks was lower compared with pre-pandemic levels, as consumers spent less and recent hot weather kept people indoors. * BAT: Lucky Strike cigarette maker British American Tobacco BATS.L reported a drop in its first-half profit, driven by impairment charges related to transfer of its Russian business.
B
F
G
G
L
S
U

UK Stocks-Factors to watch on July 27

July 27 (Reuters) - Britain's FTSE 100 index .FTSE is seen opening higher on Wednesday, with futures FFIc1 up 0.3%. * DE LA RUE: Britain's De La Rue DLAR.L has terminated its supply agreement with paper-making firm Portals Paper Ltd as the banknote printer cuts costs during a worldwide transition to polymer banknotes, the printer said on Tuesday. * REGULATOR: Britain's financial watchdog said on Wednesday it would press ahead with tougher protections for retail customers that put senior official
B
F
G
G
L
S
U

European shares trim gains on gas supply concerns

(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window) * Energy, banking, mining stocks lead gains in Europe * Just Eat, Delivery Hero rise as peer confirms margin target (Updates to close) By Susan Mathew and Bansari Mayur Kamdar July 18 (Reuters) - European stocks slipped from session highs after a report that Russia's Gazprom has declared force majeure on some gas supplies to Europe stoked worries about an energy crunch in the continent.
C
G
E
F
G

UK Stocks-Factors to watch on July 18

July 18(Reuters) - Britain's FTSE 100 index .FTSE is seen opening higher on Monday, with futures FFIc1 up 0.53%. * JOHNSON MATTHEY: Johnson Matthey JMAT.L said on Monday it is building an 80 million pound ($95.08 million) gigafactory as it looks to expand manufacturing of hydrogen fuel cell components in the UK. * GSK: British drugmaker GSK GSK.L spun off its consumer health business on Monday in the biggest listing in Europe for more than a decade.
B
G
S
J
R
U

Why world's first malaria shot won't reach millions of children who need it

By Jennifer Rigby, Natalie Grover and Maggie Fick LONDON/KISUMU, Kenya, July 13 (Reuters) - After decades of work, the World Health Organization endorsed the first-ever malaria vaccine last year - a historic milestone that promised to drive back a disease that kills a child every minute. In reality, efforts are falling well short of that, with a lack of funding and commercial potential thwarting GSK Plc's GSK.L capacity to produce as many doses of its shot as needed, according to Reuters intervi
G

British Business - July 11

July 10 (Reuters) - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy. The Times - Rishi Sunak and Grant Shapps, the prime ministerial hopefuls, should share the blame for the delays and cancellations chaos at airports this summer, Philipp Joeinig, chief executive of Menzies Aviation has said.
G
U

British Business - July 7

July 6 (Reuters) - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy. The Times - GSK GSK.L shareholders have overwhelmingly voted in support of plans to break up the drugs group through the demerger and listing of Haleon, its consumer healthcare business, later this month.
A
E
G
H

Financial Times - July 7

July 7 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines - GSK investor support for spin-off vindicates rejection of Unilever bid, says chief Link - BA to cut another 10,300 flights escalating airline disruption Link - HSBC closes in on deal to sell Russian business to Expobank Link - AO World plans £40mn capital raise after sharp share price fall Link Overview - GlaxoSmithKline's GSK.L c
G
H



Kundisyon

Mga Patok na Assets

Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.

Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.

Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.

Gumagamit kami ng cookies para mabigyan ka ng mahusay na karanasan sa aming website. Magbasa pa o palitan ang iyong cookie settings.

Babala sa Risk: Maaaring malugi ang iyong kapital. Maaaring hindi nababagay sa lahat ang mga produktong naka-leverage. Mangyaring isaalang-alang ang aming Pahayag sa Risk.